Table 5.
Parameters assessed by the reviewed studies.
| Parameter | Number of Studies | References |
|---|---|---|
| OC; cOC; ucOC; cOC/ucOC ratio | 20 | [73,76,92,94,95,96,97,98,99,100,102,103,104,105,110,111,113,114,115,118] |
| BMD | 15 | [93,94,96,99,101,102,103,105,106,112,113,114,116,117,118] |
| PINP, CTX; CTX/P1NP | 4 | [76,116,117,119] |
| IGF-1 | 3 | [98,100,102] |
| MGP; dp-ucMGP | 3 | [72,74,134] |
| BAP | 2 | [113,118] |
| Adiponectin | 1 | [76] |
| CC; DC; IMT | 1 | [71] |
| DPD | 1 | [102] |
| NO; hROS | 1 | [75] |
| NTX | 1 | [97] |
BAP—bone alkaline phosphatase; BMD—bone mineral density; CC—compliance coefficient; cOC—carboxylated osteocalcin; CTX—carbo-terminal telopeptide of type I collagen; DPD—deoxypyridinoline; dp-ucMGP—dephosphorylated–uncarboxylated MGP; hROS—highly reactive oxygen species; IGF-1—Insulin-like growth factor 1; IMT—intima–media thickness; MGP—matrix glutamate (Gla) protein; NO—nitric oxide; NTX—collagen cross-linked-N-telopeptide; OC—osteocalcin; P1NP—procollagen type 1 amino-terminal propeptide.